Prof Stefano Bonora, MD is an expert in Infectiology at Ospedale Amedeo di Savoia (Italy). Stefano Bonora has authored 536 publications, the most recent in 2026, and is an investigator in 14 clinical trials, 4 of them ongoing. SLR score: 1,325 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Stefano Bonora, MD Ospedale Amedeo di Savoia Italy
1 325 ScienceLeadR Reputation 1325
Network Map

Infectiology

Subspecialties: Pharmacy - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1997 - 2026
Source: PubMed

University of Turin

2003 - 2026

Ospedale Amedeo di Savoia

2005 - 2026

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 536

Citations

Citations: 13 429 1st author: 28 Last author: 77 Unique author: 2


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
The effect of a tailored dietary intervention on serum biomarkers and faecal microbiome composition in people with HIV at risk of cardiovascular disease.
PMID 42723559 — pilot projects, pilots, serum, cardiovascular diseases, feeding behavior, biomarkers, diet, viremia, therapeutics
HIV Med20260
Tenofovir diphosphate intracellular concentration following tenofovir alafenamide administration in bictegravir-containing vs. dolutegravir-containing antiretroviral regimens.
PMID 42963933 — tenofovir, pharmaceutical preparations, pharmacology, plasma, pharmacokinetics, dolutegravir
Br J Clin Pharmacol20260
Virological outcomes, resistance profile and viral evolution of lenacapavir-based regimens in heavily treatment-experienced people: data from the PRESTIGIO Registry.
PMID 42948967 — registries, drug therapy, capsid, viremia, therapeutics, plasma
J Antimicrob Chemother20260
Higher Risk of Loss to Follow-up Among Transgender People With HIV in Italy: Findings From the ICONA Cohort.
PMID 42871927 — retention, psychology, gender identity
Open Forum Infect Dis20260
Trends in Hepatitis D Virus Prevalence Among HBsAg-Positive Individuals With and Without HIV in Italy: A Converging Epidemiology.
PMID 42834655 — hepatitis b surface antigens, hepatitis d, epidemiology, pharmaceutical preparations, hepatitis delta virus, liver, viruses, prevalence, infections, hepatitis
Liver Int20260

Clinical Studies 14

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

Phase 4 5
Phase 3 4
Phase 2 2
N/A 1
Phase 1 1
Phase 2/Phase 3 1

By status:

Completed 7
Active not recruiting 4
Unknown 2
Terminated 1

By type:

Interventional 13
Observational 1

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 1
multicentric5to9 2
multicentricup10 8

Main Topics

Cohort/Consortium Investigators 47

Ongoing Clinical Trials

4 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Evaluating efficacy and safety of switching a boosted protease inhibitor to fostemsavir in PLWH with limited therapeutic options (FOST Switch)
2023-504192-25-00 — hiv-1, safety, hiv, peptide hydrolases, protease inhibitors, therapeutics
Phase 4Active not recruiting2024
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Na ve Persons with HIV 1 (INNOVATE Study)
2025-521918-26-00 — hiv-1, tenofovir, safety, hiv, emtricitabine, therapeutics, hiv infections, infections
Phase 2Active not recruiting2026
Early DOlutegravir LAmivudine Switching after virological suppression (EDOLAS Study)
2024-518909-18-00 — hiv-1, safety, pharmaceutical preparations, lamivudine, hiv, rna, dolutegravir
Phase 3Active not recruiting2021
Proof of concept treatment study of orally administered VH4004280 or VH4011499 in HIV 1 infected adults
2023-505350-18-00 — hiv-1, safety, capsid, hiv, therapeutics, hiv infections, antiviral agents, infections, pharmacokinetics
Phase 2Active not recruiting2023

LeadR Networks

Main global connection map